Archer Investment Corporation’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63K Hold
5
﹤0.01% 1018
2026
Q1
$2.81K Hold
5
﹤0.01% 1016
2025
Q4
$3.38K Hold
5
﹤0.01% 926
2025
Q3
$3.19K Hold
5
﹤0.01% 935
2025
Q2
$2.68K Hold
5
﹤0.01% 935
2025
Q1
$2.1K Hold
5
﹤0.01% 939
2024
Q4
$2.07K Hold
5
﹤0.01% 941
2024
Q3
$2.53K Hold
5
﹤0.01% 900
2024
Q2
$2.44K Hold
5
﹤0.01% 882
2024
Q1
$2.7K Hold
5
﹤0.01% 848
2023
Q4
$2.77K Hold
5
﹤0.01% 855
2023
Q3
$2.19K Hold
5
﹤0.01% 861
2023
Q2
$2.51K Buy
+5
New +$2.4K ﹤0.01% 832

Other funds holding IDXX

Archer Investment Corporation's IDXX Position: Q2 2026 in Review

Archer Investment Corporation held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 5 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Archer Investment Corporation first reported a position in IDXX in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.38K in Q4 2025. 939 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Archer Investment Corporation held 5 shares of Idexx Laboratories worth $2.63K as of Q2 2026.
  • Archer Investment Corporation left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #1018 holding.
  • Archer Investment Corporation first reported a position in Idexx Laboratories in Q2 2023 and has held it in 13 quarters since.
  • Archer Investment Corporation's Idexx Laboratories position peaked at $3.38K in Q4 2025.
  • 939 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.